BufferGel and PRO 2000/5: Vaginal Gels to Prevent HIV Infection in Women - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00074425

Locations


United States, Pennsylvania
	University of Pennsylvania
	Philadelphia, Pennsylvania, United States

Malawi
	Malawi College of Medicine, Queen Elizabeth Central Hospital
	Blantyre, Malawi

South Africa
	Medical Research Council - Hlabisa
	Hlabisa, South Africa
	R.K. Khan Hospital
	Chatsworth, South Africa

Tanzania
	Kilimanjaro Christian Medical Center
	Moshi, Tanzania

Zambia
	Kamwala Clinic
	Lusaka, Zambia

Zimbabwe
	Zimbabwe National Family Planning Council
	Harare, Zimbabwe, 263
	Seke South Clinic
	Harare, Zimbabwe, 263

Sponsors and Collaborators

National Institute of Allergy and Infectious Diseases (NIAID)

HIV Prevention Trials Network

Investigators


Study Chair:	Salim Abdool Karim, MBChB, PhD	University of KwaZulu-Natal, Centre for the AIDS Programme of Research in South Africa, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine

Study Chair:	Irving Hoffman, PA, MPH	School of Medicine, University of North Carolina

Study Chair:	Lisa Maslankowski, MD	University of Pennsylvania

Study Chair:	Groesbeck Parham, MD	Centre for Infectious Disease Research in Zambia

Study Chair:	Nancy Padian, PhD	Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco; AIDS Research Institute

Study Chair:	Gita Ramjee, PhD	Medical Research Council, HIV Prevention Research Unit

Study Chair:	Taha Taha, MD	Johns Hopkins Bloomberg School of Public Health